Excerpts from DBS report

Analyst: Derek Tan

Prime candidate for privatisation

Upgrade to BUY; revised TP of S$0.65. Frasers Hospitality Trust's (FHT) current price/book (P/Bk) of 0.7x is beyond the -2 standard deviation (S.D) level, and a steal compared to its historical mean of 0.92x.

Frasers Hospitality 

Share price: 


This is coupled with the sponsor’s majority stake in the REIT, making FHT the prime candidate for privatisation, in our view.

With replacement cost of hotels trending higher over the years, and attractive valuations of FHT’s portfolio, sponsor Frasers Group may look to privatise the REIT to realise the underlying value of the individual assets in the longer term.

Our new target price of S$0.65 implies a target P/Bk of 0.9x (back to historical mean), and a revised FY21F yield of 7.2% at the current share price.


Where we differ: Buyout opportunity at current levels.

The sponsor’s 62% stake in FHT stands as the highest across the sector, with FHT a prime candidate for privatisation at current levels.

The implied valuation of S$910k/room for quality assets Intercontinental Singapore and Fraser Suites Singapore trends below development costs/room, especially given the superior locations of the two assets.

We estimate that a buyout opportunity will cost S$444m at a 25% premium to current share price to gain full control of the hotel portfolio, below book value of S$523m.

Intercontinental Hotel SingaporeIntercontinental Hotel Singapore (406 rooms) is one of the 15 hotels in 6 countries under the Frasers Hospitality Trust. Photo: Company

Temporary closure in Australia and UK.

FHT has temporarily closed all the food and beverage outlets in its hotels in Sydney and Melbourne and will be progressively closing UK assets also on a temporary basis, as tighter measures are enforced by the Australian and UK government to prevent the spread of COVID19.

Fixed rent 

derek tanOur revised FY20F DPU of 1.83 Scts and yield of 3.7% constitute primarily of fixed rent (66%) from FHT’s 15 master leases.

-- Derek Tan (photo),
Analyst, DBS

We adjust our RevPAR forecasts in line with the rest of the sector, with normalisation expected to occur only in FY22.

Revised RevPAR estimates will be 47%/88% of FY19 levels for FY20/FY21.

Valuation: We revise our RevPAR forecast and beta estimates to derive a TP of S$0.65. Upgrade to BUY.

Key Risks to Our View: Slower recovery in FY21 as COVID-19 protracts.

Full report on pages 26-31 here. 

Share Prices

Counter NameLastChange
AEM Holdings4.190-0.080
Avi-Tech Electronics0.280-
Broadway Ind0.141-0.001
China Sunsine0.475-
Food Empire0.510-0.005
Fortress Minerals0.3400.015
Geo Energy Res0.3800.005
Golden Energy0.8150.035
GSS Energy0.048-
ISDN Holdings0.465-0.010
IX Biopharma0.139-0.001
Jiutian Chemical0.082-0.002
KSH Holdings0.345-
Leader Env0.050-
Medtecs Intl0.114-
Meta Health0.028-0.001
Moya Asia0.088-0.001
Nordic Group0.5300.005
Oxley Holdings0.1610.001
REX International0.240-
Sinostar PEC0.190-
Southern Alliance Mining0.6600.010
Straco Corp.0.400-
Sunpower Group0.320-0.010
The Trendlines0.094-
Totm Technologies0.126-0.003
UG Healthcare0.180-0.007
Uni-Asia Group0.950-0.025
Wilmar Intl3.950-0.020
Yangzijiang Shipbldg1.2400.140

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 470 guests and no members online